Extended-spectrum β-lactamase- producing Enterobacteriaceae in malian orphanage

Emerging Infectious Diseases

Volumn 15, Issue 3, 2009, Pages 472-474

  Tandé, Didier ^a,b   Jallot, Nelle ^a   Bougoudogo, Flabou ^c   Montagnon, Tracey ^a   Gouriou, Stéphanie ^a,b   Sizun, Jacques ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^c National Institute of Research on Public Health   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; ANTIINFECTIVE AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM CONTAMINATION; BACTERIUM ISOLATION; CHILD; CHILD CARE; CITROBACTER FREUNDII; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENVIRONMENTAL SANITATION; ESCHERICHIA COLI; FECES ANALYSIS; HUMAN; INFECTION; INFECTION CONTROL; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALI; MEDICAL STAFF; ORPHANAGE; PERSONAL HYGIENE;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CAREGIVERS; CARRIER STATE; CHILD; CHILD, ORPHANED; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INFANT; MALI; ORPHANAGES;

EID: 63849116546     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1503.071637     Document Type: Article

References (14)

1. Comité Technique National des Infections Nosocomiales. Maîtrise de la diffusion des bactéries multi-résistantes aux antibiotiques. Recommandations pour les établissements de sante. Ministère de l'emploi et de la solidarité, Secrétariat d'Etat à la Santé et à l'Action Sociale; 1999. p. 5-14.
2. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. JAMA. 1999;281:67-71. DOI: 10.1001/jama.281.1.67
3. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL- producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13:1-11 [cited 2009 Jan 26]. Available from http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=19044
4. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:1162-71. DOI: 10.1086/319757
5. Cavallo JD, Chardon H, Chidiac C, Choutet P, Courvalin P, Dabernat H et al. Comité de l'Antibiogramme de la Société Française de Microbiologie, Communiqué janvier. 2007. [cited 2009 Jan 26]. Available from http://www.sfm.asso.fr
6. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657-86. DOI: 10.1128/CMR.18.4.657-686.2005
7. Harbarth S, Samore MH. Antimicrobial resistance determinants and future control. Emerg Infect Dis. 2005;11:794-801.
8. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14:1722-30. DOI: 10.3201/eid1411.070467
9. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use in acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757-62. DOI: 10.1086/322627
10. Schwartz B. Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries: the case for judicious antimicrobial use. Clin Infect Dis. 1999;28:211-3. DOI: 10.1086/515115
11. World Health Organization. Promoting rational use of medicines: core components. Geneva. WHO/EDM/2002.3. Geneva: The Organization; 2002.
12. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, et al. Risk factors for the development of extended-spectrum betalactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23:163-7. DOI: 10.1007/s10096-003-1084-2
13. World Health Organization. Antibiotic prescribing in the West African countries: Mauritania, Niger and Senegal. (WHO/DAP/93.4). Geneva: The Organization; 1993
14. Avorn JL, Barrett JF, Davey PG, McEwen SA, O'Brien TF, Levy SB. Antibiotic resistance: synthesis of recommendations by expert policy groups. Alliance for the prudent use of antibiotics. WHO/CDS/CSR/DRS/2001.10. Geneva: World Health Organization.2001.